{"id":"339778513_Remdesivir_as_a_possible_therapeutic_option_for_the_COVID-19","authors":["Jaffar A. Al-Tawfiq","Ali H. Al-Homoud","Ziad Memish"],"meta":["March 2020Travel Medicine and Infectious Disease 34:101615","DOI:10.1016/j.tmaid.2020.101615"],"references":["338506945_Comparative_therapeutic_efficacy_of_remdesivir_and_combination_lopinavir_ritonavir_and_interferon_beta_against_MERS-CoV","337584058_A_Randomized_Controlled_Trial_of_Ebola_Virus_Disease_Therapeutics","323584104_Coronavirus_Susceptibility_to_the_Antiviral_Remdesivir_GS-5734_Is_Mediated_by_the_Viral_Polymerase_and_the_Proofreading_Exoribonuclease","318491994_Broad-spectrum_antiviral_GS-5734_inhibits_both_epidemic_and_zoonotic_coronaviruses","313341870_Nucleotide_Prodrug_GS-5734_Is_a_Broad-Spectrum_Filovirus_Inhibitor_That_Provides_Complete_Therapeutic_Protection_Against_the_Development_of_Ebola_Virus_Disease_EVD_in_Infected_Non-human_Primates","303334280_Late_Ebola_virus_relapse_causing_meningoencephalitis_A_case_report","296689461_Therapeutic_Efficacy_of_the_Small_Molecule_GS-5734_against_Ebola_Virus_in_Rhesus_Monkeys","339050950_Learning_from_the_Past_Possible_Urgent_Prevention_and_Treatment_Options_for_Severe_Acute_Respiratory_Infections_Caused_by_2019-nCoV","338959825_First_Case_of_2019_Novel_Coronavirus_in_the_United_States","337193156_MERS-CoV_as_an_emerging_respiratory_illness_A_review_of_prevention_methods"]}